Developing psychobiotic LBPs tackling the gut-brain axis

During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiomepost discussed with Anna Chwalibóg, Chief Product Officer at Integral Solutions, about the opportunity to develop next-generation microbiome-based therapeutics for mental health and cognitive enhancement using, in particular, CRISPR genome engineering.